Australia Clinical Trials Update

📣 ANZCTR Clinical Trial Update: IMMUNE‑12 Now Recruiting
We’re pleased to share that the Phase 2 clinical trial of IMMUNE‑12 for high‑grade gliomas (GBM) is actively recruiting participants at multiple sites in Australia…